small molecule

DOXYCYCLINE HYCLATE

DOXYCYCLINE HYCLATE

Loss of exclusivityloss of exclusivity
CompanySTERISCIENCE PTE LTD

Drug detail

Brand nameDOXYCYCLINE HYCLATE
Active ingredientDOXYCYCLINE HYCLATE
StrengthEQ 100MG BASE/VIAL
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalNovember 2025
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

DOXYCYCLINE HYCLATE patent cliff — loss of exclusivity — | CliffBio